Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Verlinde

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Structure (London, England : 1993)|July 15, 1994
Structure-based drug design: progress, results and challengesC L Verlinde, W G Hol
Nature Structural Biology|June 1, 1995
Drug or tool, design or serendipity?C L Verlinde, B W Dijkstra
Novartis Foundation Symposium|December 30, 1999
Molecular mechanism of visual transductionK Palczewski, C L Verlinde, F Haeseleer
Journal of Computer-Aided Molecular Design|April 1, 1992
In search of new lead compounds for trypanosomiasis drug design: a protein structure-based linked-fragment approachC L Verlinde, G Rudenko, W G Hol
Biochemistry|May 8, 1999
Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonistsW E Minke, C Roach, W G Hol, et al.
Current Opinion in Structural Biology|December 15, 2000
AB(5) toxins: structures and inhibitor designE Fan, E A Merritt, C L Verlinde, et al.
Journal of Medicinal Chemistry|May 29, 1999
The role of waters in docking strategies with incremental flexibility for carbohydrate derivatives: heat-labile enterotoxin, a multivalent test caseW E Minke, D J Diller, W G Hol, et al.
Journal of Molecular Biology|January 15, 1999
Structure-based discovery of a pore-binding ligand: towards assembly inhibitors for cholera and related AB5 toxinsB T Hovey, C L Verlinde, E A Merritt, et al.
Journal of Medicinal Chemistry|November 21, 1998
Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug designA M Aronov, C L Verlinde, W G Hol, et al.
Biochimica Et Biophysica Acta|December 8, 2000
Ca(2+)-binding proteins in the retina: from discovery to etiology of human disease(1)I Sokal, N Li, C L Verlinde, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Structure (London, England : 1993)|July 15, 1994
Structure-based drug design: progress, results and challengesC L Verlinde, W G Hol
Nature Structural Biology|June 1, 1995
Drug or tool, design or serendipity?C L Verlinde, B W Dijkstra
Novartis Foundation Symposium|December 30, 1999
Molecular mechanism of visual transductionK Palczewski, C L Verlinde, F Haeseleer
Journal of Computer-Aided Molecular Design|April 1, 1992
In search of new lead compounds for trypanosomiasis drug design: a protein structure-based linked-fragment approachC L Verlinde, G Rudenko, W G Hol
Biochemistry|May 8, 1999
Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonistsW E Minke, C Roach, W G Hol, et al.
Current Opinion in Structural Biology|December 15, 2000
AB(5) toxins: structures and inhibitor designE Fan, E A Merritt, C L Verlinde, et al.
Journal of Medicinal Chemistry|May 29, 1999
The role of waters in docking strategies with incremental flexibility for carbohydrate derivatives: heat-labile enterotoxin, a multivalent test caseW E Minke, D J Diller, W G Hol, et al.
Journal of Molecular Biology|January 15, 1999
Structure-based discovery of a pore-binding ligand: towards assembly inhibitors for cholera and related AB5 toxinsB T Hovey, C L Verlinde, E A Merritt, et al.
Journal of Medicinal Chemistry|November 21, 1998
Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug designA M Aronov, C L Verlinde, W G Hol, et al.
Biochimica Et Biophysica Acta|December 8, 2000
Ca(2+)-binding proteins in the retina: from discovery to etiology of human disease(1)I Sokal, N Li, C L Verlinde, et al.
Pageof 4